[Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000037:antagonists & inhibitors*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D012867:Skin / Q000187:drug effects; D014043:Tolazoline / Q000494:pharmacology*; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D005446:Fluocinolone Acetonide; D014043:Tolazoline
Kortikosteroideffekt und Vasokonstriktion. 1. Durchbrechung der kortikosteroidbedingten Vasokonstriktion mit Tolazolin bei Hautgesunden.